Medical University of Szeged
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Riou, Marianne
TripleTRE, NCT06317805: Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

Recruiting
4
110
Europe, RoW
Generic treprostinil sodium + Standard of Care (Double Oral), Trisuva, Tresuvi, Treposa, Treprostinil Orpha-Devel, Treprostinil Amomed, Treprostinil OrPha, Treposuvi, Standard of Care - Double Oral
AOP Orphan Pharmaceuticals AG, ANOVA CRO s.r.o., PharmaLex Belgium, Aixial s.r.o., GCP-Service International Ltd. & Co. KG
Pulmonary Arterial Hypertension
06/27
06/27
IMPAHCT-FUL, NCT05557942 / 2021-006864-25: Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension

Active, not recruiting
3
462
Europe, Canada, US, RoW
AV-101
Aerovate Therapeutics, Aerovate Therapeutics Inc
Pulmonary Arterial Hypertension
12/25
12/25
IMPAHCT, NCT05036135: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Active, not recruiting
2/3
462
Europe, Canada, US, RoW
AV-101, Placebo
Aerovate Therapeutics
Pulmonary Arterial Hypertension
12/24
01/25

Download Options